scispace - formally typeset
G

Garth J. S. Cooper

Researcher at University of Auckland

Publications -  309
Citations -  17579

Garth J. S. Cooper is an academic researcher from University of Auckland. The author has contributed to research in topics: Amylin & Insulin. The author has an hindex of 63, co-authored 299 publications receiving 16490 citations. Previous affiliations of Garth J. S. Cooper include Manchester Academic Health Science Centre & University of Manchester.

Papers
More filters
Journal ArticleDOI

Aberrant processing of plasma vitronectin and high-molecular-weight kininogen precedes the onset of preeclampsia.

TL;DR: Difference gel electrophoresis (DIGE) identified the plasma proteins vitronectin and high-molecular-weight kininogen in association with preeclampsia and may prove to be useful as early markers of fibrinolytic activity and neutrophil activation, which are known to be associated with preeClampsia.
Journal ArticleDOI

Proteomic Analysis of the Human Brain in Huntington's Disease Indicates Pathogenesis by Molecular Processes Linked to other Neurodegenerative Diseases and to Type-2 Diabetes

TL;DR: It is proposed that HTT mutations lead to or cause functional impairment of these pathways and that simultaneous restoration of their functions by targeted pharmacotherapy could ameliorate the signs and symptoms of HD.
Journal ArticleDOI

Combined angiotensin-converting enzyme inhibition and adrenomedullin in an ovine model of heart failure.

TL;DR: Short-term co-treatment with ADM and an ACE inhibitor produced significantly greater decreases in ventricular filling pressures and cardiac afterload, and increases in cardiac output, compared with either treatment alone.
Patent

Adiponectin and uses thereof

TL;DR: In this paper, the authors proposed methods and reagents for regulation of metabolic events mediated by adiponectin and its agonists, such as those mediated by metabolic events such as metabolic acidosis.
Journal ArticleDOI

Ethnic disparity of pancreatic cancer in New Zealand.

TL;DR: The Maori have higher rates of pancreatic cancer than other ethnic groups in New Zealand, and do not show the expected male predominance, which may enable targeted study to identify new markers and risk factors.